Covid vaccine should be available for public by April 2021: Serum Institute CEO
Friday, 20 November 2020 Vaccine maker Serum Institute of India's CEO Adar Poonawalla on Thursday said the Oxford Covid-19 vaccine should be available for healthcare workers and elderly people by around February 2021 and by April for the general public, and will be priced at a maximum of Rs 1,000 for two necessary doses for the public, depending on the final trial results and regulatory approvals.
The opening session of the 18th edition of the Hindustan Times Leadership Summit saw an enlightening discussion on the Covid-19 pandemic. Dr Ashish K. Jha, Dean, Brown University School of Public Health, and Dr Randeep Guleria, Director, All India Institute of Medical Sciences spoke on the race for a...
Prime Minister Narendra Modi held a virtual summit with his UK counterpart Boris Johnson on May 04. Speaking on the talks between the two leaders, MEA Joint Secretary (Europe West), Sandeep Chakraborty today said, "The two leaders (PM Modi and UK PM) also discussed the global pandemic situation and ongoing cooperation in the fight against it. PM Modi thanked PM Johnson for prompt medical assistance provided UK, in wake of severe 2nd wave in India." "UK was one of the first to respond, sending critical medical equipment, like oxygen concentrators, cylinders, ventilators, amongst others. The successful vaccine partnership through Oxford/AstraZeneca-SII collaboration was also discussed," he added.
Maharashtra Congress Chief chief Nana Patole has responded to SII chief Adar Poonawalla’s allegation that he is being threatened. Addressing the media, Patole said that Congress is worried over Poonawalla’s allegations and said that the Congress would take the responsibility of ensuring his security. He further urged Poonawalla to name those politicians who had threatened him over vaccine production. Poonawalla, who flew to London last week, is chief executive officer of the Serum Institute, which is the local maker of the coronavirus vaccine developed by Oxford University and pharmaceuticals company AstraZeneca. Watch the full video for all the details.
Credit: HT Digital Content Duration: 02:05Published
During an interview to a London newspaper, head of Serum Institute of India (SII) Adar Poonawalla, who is one of the vaccine manufacturers in India, revealed that he is receiving threats from big leaders for early transportation of COVID-19 vaccine. While taking responsibility of his protection, Maharashtra Congress president Nana Patole during a press conference asked him to reveal the names of people who had threatened him. Nana Patole said, "No one will touch him in the country, he has to carry out the vaccine production in India in order to save the people of the country. Congress is with him and will take the onus of his protection. Who are these leaders? Who has threatened him? He should bring these things in limelight."
Serum Institute of India CEO Adar Poonawalla, who has been in the UK on extended stay to evade alleged threats in India over ever-increasing demand for COVID-19 vaccines, has said he will return in a few days. In an interview to 'The Times', Poonawalla had alleged that he had been receiving threats in India and that he and his family had left the country for London after unprecedented "pressure and aggression" over the demand of COVID-19 vaccines. In a late night tweet on Saturday, he said the production of Covishield -- the Oxford/AstraZeneca's COVID-19 vaccine that is being produced by Serum Institute in India -- was in full swing at SII's facility in Pune. "Pleased to state that COVISHIELD's production is in full swing in Pune. I look forward to reviewing operations upon my return in a few days," Poonawalla said. Watch the full video for more details.
Credit: HT Digital Content Duration: 01:50Published
Serum Institute of India CEO Adar Poonawalla on Saturday spoke out about the pressures he was under over the production of COVID-19 vaccines to meet the ever-increasing demand in India as the country battles through a devastating second wave of the coronavirus pandemic. In his first comments since he was provided with ‘Y’ category security by the Indian government earlier this week, Poonawalla told ‘The Times’ in an interview about receiving aggressive calls from some of the most powerful people in India, demanding supplies of Covishield -- the Oxford/AstraZeneca COVID-19 vaccine that the Serum Institute is producing in India. Watch the full video for more details.
Credit: HT Digital Content Duration: 01:43Published
Prime Minister Narendra Modi interacted with three teams working on developing and manufacturing of vaccines against Covid-19. The teams were from Gennova Biopharmaceuticals Ltd, Biological E Ltd, and..
Credit: HT Digital Content Duration: 01:15Published